MDA Clinical and Scientific Conference 2023

MERIDIAN: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Pegcetacoplan in People with ALS

Access Resources

Effect of Complement Inhibition in an iPSC-Derived ALS Neuromuscular Junction Model of Neuroinflammation

Access Resources

Back to Conference Resources

ALS Congress Presentations

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.

MDA Clinical and Scientific Conference 2023

Back to Conference Resources

Report an Adverse Event or Product complaint

Ask a Medical Question

Connect with an MSL

Landing